The purpose of this study is to assess the extent to which engaging teachers in iterative design processes with scientists increases their content knowledge of and self-efficacy for incorporating current biomedical science into their teaching. This study includes a professional development program with a teacher-driven curriculum development component.
This study aims to evaluate a teacher-student classroom rostering tool designed to reduce inequities in student assignments.
The first 2,000 days are critical periods of child development, laying the foundation for young children's cognitive, language, and socio-emotional development. This age span is also a critical period for racial identity. Positive racial identity has been linked to Black children's achievement and socio-emotional.iii Research has found that when Black children receive messages about having positive self-worth and self-identity, balanced with messages about racial inequalities, this results in joyful learning and socio-emotional outcomes,iiiiv academic curiosity, and persistence.v Thus, a focus on positive racial identity may be one particular strategy to ensure the healthy development and learning for Black children to combat against racism and biases they are likely to experience. As evidenced by the planning grant data, Black children experience different forms of racism and inequities in their household and learning environments. We hypothesize that attending to culturally responsive teaching, and more precisely, African-centered teaching practices, is a more effective
Provides research participants for researchers in the School of Journalism & Media.
The purpose of this study is to assess the impact the UNC Eshelman School of Pharmacy (ESOP) Master of Science (MS) in Pharmaceutical Science with a specialization in Health-System Pharmacy Administration (HSPA) has on graduates and their career while also assessing the impact key curriculum requirements (e.g., projects, presentations, research, etc.) have on graduates practice site and the profession. Successful completion of this project will inform further curriculum improvement, inform programmatic design, and produce key data pivotal in the continued recruitment for the program. Most significantly, it will ensure the UNC ESOP continues to produce exceptional MS graduates capable of leading and advancing the profession of pharmacy.
To evaluate the accuracy of a new software in the prediction of growth and rupture of aortic aneurysms.
Our goal is to conduct a pilot randomized controlled trial (RCT) to evaluate the effects of Pharm-SAVES suicide prevention gatekeeper training for community pharmacy staff communication behaviors, knowledge, and self-efficacy.
1. Characterize sleep-related content in current training curricula for marijuana dispensary workers 2. Examine dispensary workers' and medical prescribers' practices around recommending cannabis products for sleep problems 3. Assess dispensary workers' and prescribers' knowledge about sleep and cannabis 4. Test the presence of THC, CBD, CBN in the products marketed for sleep
To explore cognitive burden perceptions among physicians with relation to case report writing. To understand impact of perceived workload on case report publication rates. And to identify infrastructure and AI-driven mechanisms to reduce cognitive burden among physicians in producing case reports and increasing publication.
Hunter Syndrome or Mucopolysaccharidosis II (MPS II) is a rare genetic disorder caused by decreased levels of a specific enzyme, iduronate-2-sulfatase. Lack of this enzyme causes buildup of large sugar molecules called glycosaminoglycans (GAGs). The build up of GAGs causes significant damage to the body and brain. Idursulfase-IT, an enzyme replacement therapy, was developed for the treatment of patients with Hunter Syndrome with cognitive impairment to help with the central nervous system manifestations of the disease. The purpose of this post-trial access program is so that patients with Hunter syndrome who previously received monthly administration of idursulfase-IT through participation in an earlier clinical research study can continue to receive it.